Librería: Majestic Books, Hounslow, Reino Unido
EUR 88,06
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Elsevier Science Health Science, 2026
ISBN 10: 0443294607 ISBN 13: 9780443294600
Librería: Revaluation Books, Exeter, Reino Unido
EUR 84,56
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 240 pages. 10.00x7.00 inches. In Stock.
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 102,09
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 99,39
Cantidad disponible: 3 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por Elsevier Health Sciences, 2025
ISBN 10: 0443294607 ISBN 13: 9780443294600
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
EUR 93,52
Cantidad disponible: Más de 20 disponibles
Añadir al carritoHardback. Condición: New. New copy - Usually dispatched within 4 working days.
Idioma: Inglés
Publicado por Elsevier Health Sciences, London, 2025
ISBN 10: 0443294607 ISBN 13: 9780443294600
Librería: CitiRetail, Stevenage, Reino Unido
EUR 96,72
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: new. Hardcover. In this issue of Heart Failure Clinics, guest editor Dr. Ragavendra R. Baliga brings his considerable expertise to the topic of Epigenetics of Heart Failure. Top experts in the field explore how chemical modifications to DNA and histones influence gene expression without altering the genetic code, contributing to the development and progression of heart failure. Factors such as DNA methylation, histone modifications, and non-coding RNAs can regulate key pathways involved in cardiac remodeling, inflammation, and fibrosis. Environmental influences like diet, stress, and toxins can also impact these epigenetic changes, potentially worsening heart function. Understanding these mechanisms may lead to novel therapeutic targets for preventing or treating heart failure at the molecular level.Contains 18 relevant, practice-oriented topics including DNA damage response in hereditary cardiomyopathies; novel insights from mammals of extreme longevity into genetic and epigenetic regulation of heart regeneration and repair; epigenetic control in clonal hematopoiesis and impact on heart failure; pharmacological and lifestyle interventions to modulate the epigenome in heart failure; epigenetics in dilated cardiomyopathy; and moreProvides in-depth clinical reviews on epigenetics of heart failure, offering actionable insights for clinical practicePresents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.